Education

Yale University, New Haven, Connecticut, BS Biology, 1977

Brown University Medical School, Providence, RI, MD, 1981

Medical Internship

Long Beach Veterans Hospital, University of California, Irvine, 1981

Residencies

Internal Medicine, Los Angeles County-University of Southern California Medical Center, 7/83-6/85

Neurology, McGill University Affiliated Hospitals, 7/85-6/88

Fellowship

Electroencephalography, Montreal Neurological Institute, McGill University, 7/88-7/89

Professional Licenses and Board Certifications

1994 Added Qualification in Clinical Neurophysiology

1989 Diplomate of American Board of Psychiatry and Neurology

1985 Diplomate of American Board of Internal Medicine

Licensed in Connecticut, Massachusetts, and Rhode Island

Professional Memberships

American Epilepsy Society, American Academy of Neurology, American College of Physicians

Clinical Appointments

1998-1999 Clinical Associate Professor of Neurology, Brown University

1996-1997 Clinical Assistant Professor, Department of Medicine and Neurology, School of Medicine, University of North Carolina at Chapel Hill

1994-1997 Adjunct Associate Professor of Psychology, University of North Carolina, Charlotte

Clinical Practice

2009-present Neurohospitalist, Lawrence and Memorial Hospital, New London, CT

1989-1997 Neurologist, Carolina Neurological Clinic, 1001 Blythe Blvd, Suite 601, Charlotte, NC 28203

1991-1997 Medical Director, Carolinas Epilepsy Center, Carolinas Medical Center, Charlotte, NC

1991-1997 Part-time Faculty, Department of OB-GYN, Epilepsy and Pregnancy Clinic, Carolinas Medical Center, Charlotte, NC

7/82-6/83 Emergency Room Physician, Bellwood General Hospital, Bellflower, California

Current Activities

Freelance Medical Writer/Editor. Medscape Neurology Blog, Medical Advisory Board for Accordant Health Services, Inc., Neurology Advisory Board for Vivicare, NeuroNet Advisor for CureNeuro, Section Editor for Atlas of Epilepsies (in press), and Medical Coordinator for Lingkod Timog. Reviewer for Annals of Internal Medicine (Top 10%, 2007), Epilepsia, Epilepsy and Behavior, Medical Economics, and Neurology. Berlitz English teacher.

Basic Cardiac Life Support: August 2008 (Newport Hospital, RI)

Research

1. Evaluation of equivalency of generic and brand name antiepileptic drugs 2002-present.

2. Investigator-an evaluation of lamotrigine versus carbamazepine, phenytoin, or divalproex sodium as monotherapy treatment for epilepsy patients who have failed a previous course of antiepileptic drug therapy, 5/98-1/99.

3. Investigator-a multivariate analysis of health status scores in patients with epilepsy, 7/22/97-1/1/98.

4. Investigator-rufinamide in generalized epilepsy, 3/97-12/97.

5. Investigator-ganaxolone in infantile spasms, 6/96-97.

6. Investigator-oxcarbazepine pediatric study, 6/96-12/97.

7. Investigator-UCB LO59, 9/94-12/97.

8. Investigator-vigabatrin, 9/94-12/97.

9. Investigator-vagal nerve stimulator, E04, 9/94-9/97.

10. Investigator-tiagabine phase III clinical trial, 1/93-12/97.

11. Investigator-gabapentin, 9/94-8/95.

12. Investigator-felbamate compassionate use antiepileptic drug program, 8/92-8/93.

13. Investigation of evoked potential response to auditory and electrical stimuli in teleost and elasmobranch fish. Post-doctoral scholar in neurophysiology at Scripps Institute of Oceanography, La Jolla, California, 7/84-9/84.

14. Stroboscopic applications to hydrodynamics study of swimming fish, Brachydanio rerio and Carassius auratus. Yale University Biology Department, 1/76-1/77.

15. Direct measurement with miniature pressure transducers and accelerometers of stresses encountered by swimming fish, Pomatomus saltatrix. Marine Biological Laboratory, Woods Hole, Massachusetts and the John B. Pierce Foundation, New Haven, Connecticut, 6/76-9/76.

16. Study of renal lithiasis at Yale Medical School, 5/75-8/75.

17. High speed cinematography used to investigate jaw mechanics of the primitive teleost fishes, the Osteoglossoidei. Yale Biology Department, 1/74-8/75.

18. Research assistant on specimen collecting trip through Central America to Panama, 1/74-8/74.

19. Research assistant at the Woods Hole Oceanographic Institution, Woods Hole, Massachusetts, 3/73-9/73.

Books

1. Epilepsy in Clinical Practice. Demos Medical Publications, New York, November, 2000.

2. Epilepsy: 199 Answers (A Doctor Responds to His Patients’ Questions). Demos Vermande, New York, September, 1996, second edition, 2003, third edition, 2008.

Publications

1. Harden CL, Hopp J, Ting TY, Pennell PB, French JA, Hauser WA, Wiebe S, Gronseth GS, Thurman D, Meador KJ, Koppel BS, Kaplan PW, Robinson JN, Gidal B, Hovinga CA, Wilner AN, Vazquez B, Holmes L, Krumholz A, Finnell R, Le Guen C. Practice parameter update: Management issues for women with epilepsy-Focus on pregnancy (an evidence-based review): Obstetrical complications and change in seizure frequency: Report of the
Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology 2009;73:126-132.

2. Harden CL, Meador KJ, Pennell PB, Hauser WA, Gronseth GS, French JA, Wiebe S, Thurman D, Koppel BS, Kaplan PW, Robinson JN, Hopp J, Ting TY, Gidal B, Hovinga CA, Wilner AN, Vazquez B, Holmes L, Krumholz A, Finnell R, Hirtz D, Le Guen C. Practice parameter update: Management issues for women with epilepsy-Focus on pregnancy (an evidence-based review): Teratogenesis and perinatal outcomes: Report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology 2009;73:133-141.

3. Harden CL, Pennell PB, Koppel BS, Hovinga CA, Gidal B, Meador KJ, Hopp J, Ting TY, Hauser WA, Thurman D, Kaplan PW, Robinson JN, French JA, Wiebe S, Wilner AN, Vazquez B, Holmes L, Krumholz A, Finnell R, Shafer PO, Le Guen C. Practice parameter update: management issues for women with epilepsy-Focus on pregnancy (an evidence-based review): Vitamin K, folic acid, blood levels, and breastfeeding: Report of th Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology 2009;73:142-149.

4. Patel NC, Landan IR, Levin J, Szaflarski J, Wilner AN. The use of levetiracetam in refractory status epilepticus. Seizure 2006;15(3):137-41.

5. Wilner AN. Therapeutic equivalency of generic antiepileptic drugs-results of a survey. Epilepsy and Behavior 2004;5/6:995-998.

6. French JA, Kanner AM, Bautista J, Abou-Khalil B, Browne T, Harden CL, Theodore WH, Bazil C, Stern J, Schachter SC, Bergen D, Hirtz D, Montouris GD, Nespeca M, Gidal B, Marks WJ Jr, Turk WR, Fischer JH, Bourgeois B, Wilner, A, Faught RE Jr, Sachdeo RC, Beydoun A, Glauser TA; Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology; Quality Standards Subcommittee of the American Academy of Neurology; American Epilepsy Society. Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology 2004;62(8):1252-60.

7. French JA, Kanner AM, Bautista J, Abou-Khalil B, Browne T, Harden CL, Theodore WH, Bazil C, Stern J, Schachter SC, Bergen D, Hirtz D, Montouris GD, Nespeca M, Gidal B, Marks WJ Jr, Turk WR, Fischer JH, Bourgeois B, Wilner A, Faught RE Jr, Sachdeo RC, Beydoun A, Glauser TA; Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology; Quality Standards Subcommittee of the American Academy of Neurology; American Epilepsy Society. Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy; report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology 2004;62(8):1261-73.

8. French JA, Kanner AM, Bautista J, Abou-Khalil B, Browne T, Harden CL, Theodore WH, Bazil C, Stern J, Schachter SC, Bergen D, Hirtz D, Montouris GD, Nespeca M, Gidal B, Marks WJ, Turk WR, Fischer JH, Bourgeois B, Wilner A, Faught RE, Sachdeo RC, Beydoun A, Glauser TA. Efficacy and tolerability of the new antiepileptic drugs, I: Treatment of new-onset epilepsy: Report of the TTA and QSS subcommittees of the American Academy of Neurology and the American Epilepsy Society. Epilepsia 2004;45:401-409.

9. French JA, Kanner AM, Bautista J, Abou-Khalil B, Browne T, Harden CL, Theodore WH, Bazil C, Stern J, Schachter SC, Bergen D, Hirtz D, Montouris GD, Nespeca M, Gidal B, Marks WJ, Turk WR, Fischer JH, Bourgeois B, Wilner A, Faught RE, Sachdeo RC, Beydoun A, Glauser TA. Efficacy and tolerability of the new antiepileptic drugs, II: Treatment of refractory epilepsy: Report of the TTA and QSS subcommittees of the American Academy of Neurology and the American Epilepsy Society. Epilepsia 2004;45:410-423.

10. Wilner AN. Physicians underestimate the frequency of generic carbamazepine substitution: results of a survey and review of the problem. Epilepsy and Behavior 2002; 13(6):522-525.

11. Sheen VL, Dixon PH, Fox JW, Hong SE, Kinton L, Sisodiya SM, Duncan JS, Dubeau F, Scheffer IE, Schachter SC, Wilner A, Henchy R, Crino P, Kamuro K, DiMario F, Berg M, Kuzniecky R, Cole AJ, Bromfield E, Biber M, Schomer D, Wheless J, Silver K, Mochida GH, Berkovic SF, Andermann F, Andermann E, Dobyns WB, Wood NW, Walsh CA. Mutations in the X-linked filamin 1 gene cause periventricular nodular heterotopia in males as well as in females. Hum Mol Genet 2001;10 (17):1775-83.

12. Glauser TA, Nigro M, Sachdeo R, Pasteris LA, Weinstein S, Abou-Khalil B, Frank LM, Grinspan A, Guarino T, Bettis D, Kerrigan J, Geoffroy G, Mandelbaum D, Jacobs T, Mesenbrink P, Kramer L, D’Souza J, and the Oxcarbazepine Pediatric Study Group. Adjunctive therapy with oxcarbazepine in children with partial seizures. Neurology 2000;54:2237-2244 (participant).

13. Cereghino JJ, Biton V, Abou-Khalil B, Dreifuss F, Gauer LJ, Leppik, I and the United States Levetiracetam Study Group: Levetiracetam for partial seizures. Results of a double-blind, randomized clinical trial. Neurology 2000;55:236-242 (participant).

14. Wilner AN, Raymond, KH and Pollard, RJ: Topiramate and metabolic acidosis. Epilepsia 1999;40:792-795.

15. Schachter SC, Ito M, Wannamaker B, Rak I, Ruggles K, Wilner A, Jackel R, Gilliam F, Morris G, Skantz J, Sperling M, Buchhalter J, Drislane F, Ives J, Schomer D: Incidence of spikes and paroxysmal rhythmic events in overnight ambulatory computer-assisted EEGs of normal subjects: a multicenter study. J. Clinical Neurophysiology 1998;15:251-255.

16. The STIPAS Investigators: Safety study of tirilazad mesylate in patients with acute ischemic stroke (STIPAS). Stroke, 1994, Vol. 25, No. 2, pp. 418-423 (participant).

17. Wilner AN and Bream PR: Status epilepticus and pseudostatus epilepticus. Seizure, 1993;2:257-260.

18. Gewitz H, Wilner A, Garriepy S, Ree HJ, and Most A: A diagnosis of left-ventricular mural thrombus by means of radionuclide ventriculography. J. of Nuclear Medicine, 1981, 22:610-612.

19. Skinner HCW, Osbaldiston GW, and Wilner AN: Monohydrocalcite in a guinea pig bladder stone, a novel occurrence. American Mineralogist, 1977, 62:273-277.

Abstracts

1. Wilner A, Elixhauser A. Increase in hospitalizations for epilepsy from 2000 to 2006. Epilepsia 2008.

2. Wilner AN: International League Against Epilepsy creates online discussion group. Epilepsia 2006, Vol 47, Suppl 4.

3. Wilner AN: Results of switching to generic antiepileptic drugs in the treatment of epilepsy. Epilepsia 2004, Vol 45, Suppl. 7, p. 138.

4. Wilner AN: Physicians underestimate the frequency of generic carbamazepine substitution: results of a survey and review of the problem. Epilepsia 2002, Vol. 43, Suppl. 7, p. 203.

5. Wilner AN and Eisenberg DP: Repeat electroencephalograms in patients presenting with syncope versus seizure. Epilepsia, 1999, Vol. 40, Suppl. 7, p. 166.

6. Wilner AN and Bivens JG: Efficacy, tolerability, and weight loss in adults with intractable epilepsy on the ketogenic diet. Epilepsia, 1998, Vol. 39, Suppl. 6, p. 195.

7. Dodson WE, Bourgeois BFD, Shields WD, Kerrigan JF, Bluestone DL, Nelson TY, Wilner AN, Pellock JM, Morton LD, Densel MB, Lee DA, Monaghan EP: Ganaxalone in the treatment of refractory infantile spasms. Dublin Epilepsy Meeting, June, 1997.

8. Wilner AN, Band-Presnell A, Dozier F, Tarver WB: Magnet activation of the vagal stimulator provides additional seizure control. Epilepsia, 1996, Vol. 37, Suppl. 5, p. 92.

9. Connell BE, Wilner AN: MMPI-2 distinguishes intractable epilepsy from pseudoseizures: a replication. Epilepsia, 1996, Vol. 37, Suppl. 5, p. 19.

10. Wilner AN, Arnold PB, Ballinger WE: Relative value of PET and SPECT in presurgical epilepsy patients. Epilepsia, 1995, Vol. 36, Suppl. 4, p.14.

11. Connell BE, Wilner AN: Assessment of personality, adjustment to seizures, and quality of life in patients with intractable epilepsy versus pseudoseizures. Epilepsia, 1995, Vol. 36, Suppl. 4, p.101.

12. Connell BE, Harver A, Tebbutt D, Wilner AN: Assessment of quality of life by QOLI and QOLIE yields differential effects in patients with intractable epilepsy vs pseudoseizures. Archives of Clinical Neuropsychology, 1996, Vol. 11, No. 5, pp. 377-378.

13. Tebbutt D, Harver A, Wilner AN: Evaluating quality of life in difficult epilepsy with the QOLIE-89: Comparisons between seizure and pseudoseizure patients. Epilepsia, 1995, Vol. 36, Suppl. 4, p. 102.

14. Wilner AN, Farkouh M: Pseudoseizures in the elderly. Epilepsia, 1994, Vol. 35, Suppl. 8, p.11.

15. Brockway JP, Follmer RL, Wilner AN, Naegele CS: Temporal lobe epilepsy adversely affects the long-term ability to see a face and say the name of this face: Epilepsia, 1994, Vol. 35, Suppl. 8, p. 74.

16. Bustamente D, Harver A, Wilner A: Intellectual function, psychopathology, and psychosocial assessment in epilepsy and pseudoseizure: A prospective evaluation. Epilepsia, 1994, Vol. 35, Suppl. 8, p. 78.

17. Wilner AN, Loring C, Connell B, Arnold PB: Gender ratio of nonepileptic seizures varies as a function of age. Epilepsia, 1993, Vol. 34, Suppl. 6, p. 29.

18. Wilner AN, Connell B: Correct prediction of right and left temporal lobe seizure foci using tests of design and verbal learning. Epilepsia, 1993, Vol. 34, Suppl. 6, p. 87.

19. Stewart JD, Wilner A: Are new F-response parameters more sensitive in detecting abnormalities than the traditional minimal latency measurements and which new parameters are the most sensitive? (AAEE, San Diego, 1988).

20. DuBois AB, Fox RS, Wilner AN: Gravitational tolerance in Bluefish (Pomatomus saltatrix). Federation Proceedings, 1977, No. 3, 36:443.

21. DuBois AB, Fox RS, Wilner AN, Lambertson RH: Blood pressure and locomotion in Bluefish (Pomatomus saltatrix). Biological Bulletin, 1976, No. 2, 151:407.

Fiction

1. The one that got away. Toowrite.com; 2002; www.toowrite.com/comp6/0152.shtml.

2. That’s it! Neurology, 2002, Vol. 58, No. 1, p. 152.

3. At the doctor’s office, Annals of Internal Medicine, 1995, Vol. 123, No. 5, p. 388.

4. Michael LaCombe, Ed. On being a doctor, Her daughter in my office. American College of Physicians, 1995.

5. A class revisited, Mediphors, Spring 1994, No. 3, p. 54.

6. The smile, Mediphors, Spring 1993, No. 1, p. 31.

7. Her daughter in my office, Annals of Internal Medicine, 1992, Vol. 116, No. 12, p. 1031.

8. Jessica Bryan, Ed. Love is ageless, I know, Dr. Alzheimer, Serala Press, Oakland, California, 1987, pp. 9-14.

9. Life with Harry, The Yale Literary Magazine, 1977, Vol. 146, No. 1, p. 28.

Films

1. The Last Sentence (2005) (Screenplay) (2005 Newport International Film Festival-open call)

2. Polar Bear Plunge (2006) (Documentary 16.5 minutes) (2006 Newport International Film Festival-open call)

Other Publications

1. Guest Co-Editor with Selim Benbadis, MD, of a Special Focus issue of the journal Therapy, published by FutureMedicine, on emerging treatment/management strategies in epilepsy (in preparation).

2. Book Review. The treatment of epilepsy. 3^rd ed. Shorvon S, Perucca E, Engel Jr., J. Wiley-Blackwell, Chichester, 2009. Epilepsy and Behavior 2009, Volume 17, Issue 1, January 2010, pages 130-131.

3. Letter to the Editor. Lost in a Jungle of Evidence: We need a Compass; Practice Parameter and Technology Assessments: What They Are, What They Are Not, and Why You Should Care. Neurology 2009;73(16): 1337. (October, 2009) http://www.neurology.org/cgi/content/full/73/16/1337?etoc.

4. Guest Editor for Pharmaceuticals special issue on Generic Drugs, April 2010.

5. New York Presbyterian Hospital Psychiatry Newsletter, Fall, 2008.

6. New York Presbyterian Hospital Neuroscience Newsletter, Fall, 2008.

7. Case 101. If At First You Don’t Succeed…In:Puzzling Cases of Epilepsy, 2nd Edition, Editors Dieter Schmidt, Steven C. Schachter, Elsevier Inc, Academic Press, 2008

8. The death of Churchill. Woods Hole Currents 2005;10(4):15.

9. A guide to controlling seizures. Living with Epilepsy 2004;5(4):4-6.

10. New director lands at bird sanctuary. Newport This Week, April 1, 2004.

11. Letter to the editor. Alert Diver, March/April, 2004, pp 4-5.

12. Winter is prime time for seal spotting. Newport This Week, January 8, 2004, pp 6, 23.

13. Physicians and the press: What to say, what not to say. Medical Economics, July 11, 2003;80:87.

14. Book Review. Lucky Man: A Memoir. Journal of American Medical Association 2002;288:2337-8.

15. Schachter SC and Schmidt D, editors. 110 Puzzling Cases of Epilepsy, pp. 168-171. Martin Dunitz Ltd, London, 2002.

16. When it’s right to be wrong. Cortlandt Forum, June 1999, Volume 12, Number 6, p. 71.

17. New medication options for patients with epilepsy. Medicine and Health/Rhode Island, December 1998, Volume 81, Number 12, pp. 406-7.

18. Schachter SC and Rowan AJ, editors: The Brainstorms Healer, pp. 64-66, Lippincott-Raven, Philadelphia, PA, 1998.

19. Ask the doctor. Charlotte Observer, January 13, 1997.

20. Lessons of a dilated pupil. Cortlandt Forum, May 1996, Volume 9, Number 5, pp. 146-7.

21. Downside of generics isn’t news to MD’s. Charlotte Observer, March 28, 1996 (letter).

22. Walking wounded. Cortlandt Forum, February 1996, Volume 9, Number 2, p. 61.

23. When one diagnosis is not enough. Cortlandt Forum, December 1995, Volume 8, Number 12.

24. Ask the doctor. Charlotte Observer, October 16, 1995.

25. Online: Diagnosis and Information via the Internet. Mecklenburg County Medical Society Bulletin, October 1995, p. 17.

26. Info highway lets doctors pool our skills. Charlotte Observer, Thursday, July 13, 1995.

27. An elderly woman with acute altered mental status. Physician Assistant Magazine, November 1995, Volume 19, Number 11.

28. ‘Small’ spells are also seizures. Cortlandt Forum, February 1995, Volume 8, Number 2 (letter).

29. Book Review, Journal of American Medical Association, 1995, Volume 273, Number 10, p. 823.

30. Ask the doctor. Charlotte Observer, January 2, 1995.

31. The healing hand. North Carolina Medical Journal, December 1994, Volume 55, Number 12.

32. Book review. Journal of American Medical Association, 1994, Volume 271, Number 3, p. 246.

33. Wilner AN: Efficacy of felbamate monotherapy. Annals of Neurology, June 1993, Volume 33, Number 6, p. 661 (letter).

34. Ask the doctor. Charlotte Observer, April 5, 1993.

35. There’s magic mingling with the manatees. Charlotte Observer, Thursday, April 1, 1993.

36. Book review. Journal of American Medical Association, 1992, volume 267, Number 11, pp. 1540-1.

37. Editors, Matthews PM, Arnold DL. Diagnostic tests in neurology. Book chapter, Evoked potentials in the evaluation of visual and auditory pathways. Churchill-Livingstone, 1991.

38. Running into trouble. Cortlandt Forum, September 1992, p. 66.

39. Ask the doctor. Charlotte Observer, March 25, 1991.

Applied Neurology

1. Is there a BENEFIT to treating CIS early? July 2007;3(7):41-42.

2. Hedonistic homeostatic dysregulation syndrome: Too much of a good thing? 2006;1(10):35-36.

3. Advances in neurorehabilitation: Turning thoughts into action. July 2006, pp D3, D4, D6.

4. New vs old AEDs. 2005;1 (11):14-26.

CNS News

1. Overinterpretation of EEGs leads to misdiagnosis of epilepsy. May 2008, Vol 10, No 1, p 13.

2. FDA: Antiepileptic drugs increase risk for suicide. May 2008, Vol 10, No 1, p 13.

3. Genetic heterogeneity of MS patients influences response to β-interferon. May 2008, Vol 10, No 1, p 9.

4. Autism susceptibility gene identified. April 2008, Vol 10, No 4, p 7.

5. Minocycline improves stroke outcomes. April 2008, Vol 10, No 4, p 13.

6. Phase II trial of methotrexate shows positive outcomes for some lymphoma patients. April 2008, Vol 10, No 4, p 14.

7. SANAD study offers recommendations for partial, generalized, unspecialized seizure treatment. April 2008, Vol 10, No 4, p 15.

8. Study: air pressure does not affect seizure frequency. April 2008, Vol 10, No 4, p 15.

9. Childhood mood problems may occur in epilepsy. February 2008, Vol 10, No 2, p 1,7,8.

10. Familial and sporadic hemiplegic migraine share genetic link. February 2008, Vol 10, No 2, p 11.

11. Interferon beta-1b delays disability in BENEFIT study. February 2008, Vol 10, No 2, p 11.

12. Developmental delay associated with antiepileptic drugs in India. October 2007, Vol 9, No 10, p 35.

13. Genetic polymorphism speeds carbamazepine metabolism. October 2007, Vol 9, No 10, p 18.

14. Antiepileptic drug prescriptions often not refilled. October 2007, Vol 9, No 10, p 18.

15. Researchers find sleep disturbances common in menopause. October 2007, Vol 9, No 10, p 12, 17.

16. Brief test of wakefulness effective in healthy subjects. October 2007, Vol 9, No 10, p 12.

17. Study shows strong link between shift work, poor sleep in police officers. October 2007, Vol 9, No 10, p 12.

18. Study confirms efficacy of rotigotine patch in calming restless legs. September 2007, Vol 9, No 9, p 10.

19. STOP questionnaire screens sleep apnea preoperatively. September 2007, Vol 9, No 9, p 10.

20. Premenstrual dysphoric disorder found to be common in epilepsy. August 2007, Vol 9, No 8, p 1, 29.

21. Few individuals with nonepileptic seizures have true epilepsy. August 2007, Vol 9, No 8, p 28, 30.

22. AAN tackles issue of generic antiepileptic drugs. July 2007, Vol 9, No 7, p 10, 11.

23. Involuntary emotional expression disorder underdiagnosed. July 2007, Vol 9, No 7, p 15.

24. Small study supports theory that meditation can improve seizure control. June 2007, Vol 9, No 6, p 16, 30.

25. Stat EEGs expose subclinical status epilepticus. May 2007, Vol 9, No 5, p 20.

26. Inadequate vitamin D levels found in children with intractable epilepsy. May 2007, Vol 9, No 5 p 20, 39.

27. Sleep disturbances are common comorbities in epilepsy patients. May 2007, Vol 9, No 5, p 21.

28. Deep brain stimulation lowers medication costs in men in small study. May 2007, Vol 9, No 5, p 34.

29. Teens with epilepsy shun group sports. April 2007, Vol 9, No 4, p 1, 29.

30. Impulse dyscontrol may occur in patients with Parkinson’s disease. April 2007, Vol 9, No 4, p 1, 29.

31. Cognitive impairment decreases function in Parkinson’s disease. April 2007, Vol 9, No 4, p 6.

32. Gene associated with seizure susceptibility. April 2007, Vol 9, No 4, p 11.

33. Study: Epilepsy treatment improves language function in children. April 2007, Vol 9, No 4, p 12, 23.

34. New onset juvenile myoclonic epilepsy associated with cognitive deficits. April 2007, Vol 9, No 4, p 13.

35. Wireless EEG speeds diagnosis of epilepsy in the emergency room. April 2007, Vol 9, No 4, p 13.

36. Elevated tumor necrosis factor found in cerebrospinal fluid of autistic children. April 2007, Vol 9, No 4, p 18.

37. Human endogenous retrovirus-K18 increases risk for multiple sclerosis. April 2007, Vol 9, No 4, p 24.

38. Study sheds light on genetics of severe multiple sclerosis. April 2007, Vol 9, No 4, p 24.

39. Neutralizing antibodies block effects of MS therapy. April 2007, Vol 9, No 4, p 25.

40. eNos gene associated with vasospasm. March 2007, Vol 9, No 3, p 10.

41. Continuous EEG monitoring assists in subarachnoid hemorrhage prognosis. March 2007, Vol 9, No 3, p 10.

42. Screening tool reveals depression in epilepsy patients. March 2007, Vol 9, No 3, p 18, 34.

43. C-reactive protein predicts brain edema. March 2007, Vol 9, No 3, p 23.

44. Gamma knife surgery decreases seizures, preliminary data suggest. March 2007, Vol 9, No 3, p 24.

45. Atkins diet may decreases seizures in patients with intractable epilepsy. March 2007, Vol 9, No 3, p 24.

46. Psychiatric history affects epilepsy surgery outcome. March 2007, Vol 9, No 3, p 27.

47. Metabolic disease common in severe pediatric epilepsy. March 2007, Vol 9, No 3, p 27.

48. Underestimated ADHD prevalence seen in pediatric epilepsy. February 2007, Vol 9, No 2. p 1, 10.

49. TAT associated with stroke outcome. February 2007, Vol 9, No 2, p 26.

50. Impulse dyscontrol may occur in patients with Parkinson’s disease. February 2007, Vol 9, No 2, p 27.

51. PET shown to differentiate dementia types. January 2007, Vol 9, No 1, p 22, 23.

52. Acute stroke often followed by seizures in children October 2006, Vol 8, No 10, p 14.

53. Study examines rates of carotid imaging in TIA and stroke. October 2006, Vol 8, No 10, p 14, 15.

54. Low yield seen for echocardiography in ischemic stroke. October 2006, Vol 8, No 10, p 15.

55. Early treatment with spinal cord stimulation likely to succeed. October 2006, Vol 8, No 10, p 40.

56. Sleep apnea symptoms slip by the QOLIE 89. September 2006, Vol 8, No 9, p 35.

57. Sleep apnea may impair stroke recovery-at least on imaging. September 2006, Vol 8, No 9, p 35.

58. Stroke recovery not affected by presence of comorbidities, study shows. September 2006, Vol 8, No 9, p 36.

59. Extreme blood pressure a poor prognostic sign after stroke. September 2006, Vol 8, No 9, p 36.

60. Study described idiopathic intracranial hypertension in children. September 2006, Vol 8, No 9, p 34.

61. Rapid relief of migraine and Allodynia seen with occipital nerve block. September 2006, Vol 8, No 9, p 28.

62. ALS patients at high risk of deep vein thrombosis. September 2006, Vol 8, No 9, p 39.

63. Splitting headache experts: The debate over migraine surgery. September 2006, Vol 8, No 9, p 1, 30, 31.

64. Oral contraceptive use associated with less disability in MS. August 2006, Vol 9, No 8, p 1, 25.

65. Interferon delays development of multiple sclerosis. August 2006, Vol 9, No 8, p 25.

66. Ketogenic diet reduces long-term incidence of seizures. August 2006, Vol 9, No 8, p 34, 35.

67. Orthopedic surgery well tolerated by patients with Parkinson’s disease. August 2006, Vol 9, No 8, p 47.

68. Quality of life may not improve despite successful surgery. August 2006, Vol 9, No 8, p 34.

69. Nonepileptic seizures can be identified in children by video/EEG. July 2006, Vol 8, No 7, p 7,

70. Vagus nerve stimulation safe, effective in small pediatric study. May 2006, Vol 9, No 5, p 45.

71. Behavior problems often untreated in children with epilepsy. May 2006, Vol 9, No 5, p 45.

72. Study: Safe to stop antiepileptic drugs in epilepsy monitoring unit. May 2006, Vol 9, No 5, p 47.

73. Dietary treatment options for intractable epilepsy revised. April 2006, Vol 8, No 4, p 24.

74. Conversion disorder most common cause of nonepileptic seizure. April 2006, Vol 8, No 4, p 24.

75. Sleep apnea symptoms may be to blame for some seizures. April 2006, Vol 8, No 4. p 1, 25.

76. New tool helps confirm unique mood disorder in epilepsy. March 2006, Vol 8, No 3, p 1, 16.

77. Brain hemorrhage severity depends upon etiology. March 2006, Vol 8, No 3, p 9.

78. Emergency plan should be a staple of epilepsy management. March 2006, Vol 8, No 3, p 15.

79. Hormonal changes linked to seizure frequency in women with epilepsy. March 2006, Vol 8, No 3, p 16.

80. Imaging study reveals hidden epileptic activity in autism. March 2006, Vol 8, No 3, p 18.

81. Stroke team improves time to t-PA. February 2006, Vol 8, No 2, p 1, 33.

82. Criteria, symptom overlap hamper post-polio syndrome recognition. February 2006, Vol 8, No 2, p 8.

83. Negative portrayal of epilepsy dominates film and TV imagery. February 2006, Vol 8, No 2, p 8.

84. Hippocampal sclerosis likely in dementia. February 2006, Vol 8, No 2, p 28.

85. Preeclampsia increases risk of postpartum stroke. February 2006, Vol 8, No 2, p 36.

86. Youth, diabetes and ischemic stroke: a deadly combination? January 2006, Vol 8, No 1, p 16.

87. Prolactin may distinguish among seizures, but not all agree. November 2005,Vol 7, No 11, p 1, 17.

88. Acute partial transverse myelitis may lead to multiple sclerosis. November 2005, Vol 7, No 11, p.

89. Canalith repositioning treatment eliminates vertigo. November 2005, Vol 7, No 11, p 30.

90. Older antiepileptics increase fracture risk, but vitamin D has mediating effect. November 2005, Vol 7, No 11, p 16.

91. Risk of drowning increased in epilepsy patients. November 2005, Vol 7, No 11 p.

92. Prescribing during hospitalization significantly improves post-stroke compliance. November 2005, Vol 7, No 11, p 7.

93. New antiepileptic drug treats seizures of Lennox-Gastaut syndrome. November 2005, Vol 7, No 11, p 17.

94. Study shows risk of seizures increased eightfold in Alzheimer’s disease. November 2005, Vol 7, No 11, p 27.

95. Deep brain stimulation for Parkinson’s may result in weight gain. November 2005, Vol 7, No 11, p 28.

96. Postmenopausal estrogen does not prevent Alzheimer’s disease. November 2005, Vol 7, No 11, p 28.

97. Analysis shows depression drives cognitive complaints in MS. November 2005, Vol 7, No 11, p 43.

98. Psychosis and orofacial dyskinesia suggest new syndrome. October 2005, Vol 7, No 10, p 4.

99. Successful extubation criteria defined for Guillain-Barre. October 2005, Vol 7, No 10, p 5.

100. Study finds young-onset migraine more likely to be familial. October 2005, Vol 7, No 10, p 15.

101. Study: Episodic tension type most common headache seen in elderly. October 2005, Vol 7, No 10, p 16.

102. Pregabalin relieves spinal cord pain in first large-scale trial. October 2005, Vol 7, No 10, p 16.

103. Cognitive decline starts early in Parkinson’s disease. October 2005, Vol 7, No 10, p 17.

104. History and physical key to accurate diagnosis of movement disorders. October 2005, Vol 7, No 10, p 18.

105. Psychiatric symptoms frequently accompany temporal lobectomy. October 2005, Vol 7, No 10, p 19.

106. ER resident curriculum addresses common neuro diagnoses. October 2005, Vol 7, No 10, p 23.

107. Ginkgo biloba improves cognition in MS according to Stroop test. September 2005, Vol 7, No 9, p 32.

108. Compliance is key to relief of transformed migraine, study finds. September 2005, Vol 7, No 9, p 19.

109. Driving competence difficult to assess in mild dementia. September 2005, Vol 7, No 9, p 17.

110. Eye movement abnormalities mirror damage in neurodegenerative disease. September 2005, Vol 7, No 9, p 18.

111. Cosyntropin relieves low-pressure headache in open-label trial. August 2005, Vol 7, No 8, p 42.

112. ‘Scratch-and-Sniff’ leads to Parkinson’s disease diagnosis. August 2005, Vol 7, No 8, p 1, 36.

113. Combination video monitoring captures nocturnal events. July 2005, Vol 7, No 7, p 1, 14.

114. Trimebutine speeds migraine relief. July 2005, Vol 7, No 7, p 11.

115. Cannabis-based medicine improves sleep in patients with MS, Pain. July 2005, Vol 7, No 7, p 33.

116. Pregnancy registries expose teratogenic antiepileptic drugs. June 2005, Vol 7, No 6, p 26.

117. Left-handedness common in epilepsy. June 2005, Vol 7, No 6, p 26.

118. Survey describes sleep, behavior issues in children with epilepsy. May 2005, Vol 7, No 5, pp 14-15.

119. Alternative therapies often used in new pediatric epilepsy cases. May 2005, Vol 7, No 5, p 16.

120. New details discovered about rare form of epilepsy. May 2005, Vol 7, No 5, p 17.

121. ADHD often goes unrecognized in pediatric epilepsy. May 2005, Vol 7, No 5, p 17.

122. Study shows ‘abortion pill’ RU-486 may alleviate depression. April 2005, Vol 7, No 4, p 11.

123. Cause of potential neuronopathy may be dorsal root lesion. April 2005, Vol 7, No 4, p 13.

124. Half of post-stroke falls occur in first week. April 2005, Vol 7, No 4, p 21.

125. Uncontrolled seizures associated with neuropsychological decline. April 2005, Vol 7, No 4, p 24.

126. Alzheimer’s patients with parkinsonism more likely to nap. April 2005, Vol 7, No 4, p 26.

127. Mother’s psychopathology may affect children with seizures. April 2005, Vol 7, No 4, p 43.

128. Study: Patients with benign MS do well without treatment. February 2005, Vol 7, No 2, p 1, 12.

129. Low literacy undermines patient education efforts, impairs utilization. February 2005, Vol 7, No 2, p 1, 54.

130. Medical illness complicates psychiatric care. February 2005, Vol 7, No 2, p 7.

131. Rapid cyclers most likely to relapse, statistical analysis shows. February 2005, Vol 7, No 2, p 13.

132. Outpatient EEG/video often makes psychogenic seizure diagnosis. February 2005, Vol 7, No 2, p 7.

133. Hallucinations signal poor prognosis in Alzheimer’s. October 2004, Vol 6, No 10, p 19.

134. Exercise lowers risk for Parkinson’s disease in men. October 2004, Vol 6, No 10, p 36.

135. Study: Cholinesterase inhibitor safe but not cognition-enhancing. October 2004, Vol 6, No 10, p 37.

136. Higher betaseron dose decreases MRI lesions in partial responders. October 2004, Vol 6, No 10, p 38.

137. Coenzyme Q may prevent migraine. October 2004, Vol 6, No 10, p 48.

138. Ictal stuttering in adults suggests psychogenic seizures. September 2004, Vol 6, No 9, p 1, 17.

139. Polytherapy may be best choice in migraine prevention. September 2004;Vol 6, No 9, p 6, 8.

140. New blood test seeks ‘molecular signature’ to diagnose multiple sclerosis. September 2004, Vol 6, No 9, p 1, 42.

141. Allodynia examined in patients with migraine, other headache disorders. September 2004, Vol 6, No 9, p 7.

142. Study attributes migraine/infertility link to thrombophilia. September 2004, Vol 6, No 9, p 8, 9.

143. Nasal spray quickly extinguishes migraine pain, study shows. September 2004, Vol 6, No 9, p 10.

144. Altitude lessons for sea-level headache. August 2004, Vol 6, No 8, p. 1,15.

145. Analgesic overuse associated with abnormal PET images. August 2004, Vol 6, No 8, p 14.

146. Predictors of stroke in women with migraine further elucidated. August 2004, Vol 6, No 8, p 33.

147. High incidence of migraine in women with chronic pelvic pain. August 2004, Vol 6, No 8, p 14.

148. Does increased risk of ALS in military date back to World War I? July 2004, Vol 6, No 7, p 26.

149. Idiopathic generalized epilepsy more common in females than males. June 2004, Vol 6, No 6, p 42.

150. Hypointensities correlate with ambulatory, cognitive dysfunction. June 2004, Vol 6, No 6, p 48.

151. Study: Video-EEG sorts out post-traumatic seizure types. May 2004, Vol 6, No 5, p 32.

152. New brain tissue program matches donors, epilepsy researchers. May 2004, Vol 6, No 5, p 28.

153. Cognitive decline common in amyotrophic lateral sclerosis. April 2004, Vol 6, No 4, p 30.

154. African-Americans experience more severe MS symptoms. April 2004, Vol 6, No 4, pp 68-69.

155. Early menopause detected in women with epilepsy. April 2004, Vol 6, No 4, p 80.

156. Study supports reduction in AEDs. April 2004, Vol 6, No 4, p 81.

157. Idiopathic generalized epilepsy often mistreated. April 2004, Vol 6, No 4, p 81.

158. Elevated serum calcium linked to carotid plaque development. April 2004, Vol 6, No 4, p 86.

159. Will billable online consultation replace costly telephone time? March 2004, Vol 6, No 3, pp 1, 50.

160. Unilateral subthalamic stimulation shown effective in Parkinson’s. March 2004, Vol 6, No 3, pp 8, 79.

161. Magnetic resonance spectroscopy in mild cognitive impairment: Imaging predicts progression to Alzheimer’s disease. March 2004, Vol 6, No 3, p 18.

162. Study: Multiple sclerosis more often benign than disabling. March 2004, Vol 6, No 3, pp 31-32.

163. Risk factors found for poor subarachnoid hemorrhage outcome. March 2004, Vol 6, No 3, pp 69, 72.

164. Abnormal sleep decreases attention in children with primary generalized epilepsy. March 2004, Vol 6, No 3, pp 74-75.

165. Depression correlates with seizure severity. March 2004, Vol 6, No 3, p 75.

166. Implant detects, then aborts, seizures. March 2004, Vol 6, No 3, pp 76, 80.

167. Studies show elderly respond to newer antiepileptics. March 2004, Vol 6, No 3, p 85.

168. Early stroke recovery: a risk factor for deterioration? February 2004, Vol 6, No 2, p 8.

169. Rehabilitation prolongs survival, decreases pain in veterans with spinal epidural metastases. February 2004, Vol 6, No 2, p 21.

170. Experts focus on mental health issues in epilepsy. February 2004, Vol 6, No 2, pp 58-59.

171. Lessons can be learned from low rate of PTSD in sub disaster. November 2003, Vol 5, No 11, p 7, 16.

172. Does insomnia increase risk of postpartum psychosis? November 2003, Vol 5, No 11, p 51.

173. STEP-BD data characterize bipolar patients at high risk of suicide. November 2003, Vol 5, No 11, p 58.

174. Study finds children with social anxiety respond to paroxetine. October 2003, Vol 5, No 10, p 39.

175. Portion control diet helps residents lose weight. October 2003, Vol 5, No 10, p 50.

176. Experts debate higher rates of diabetes in schizophrenia patients. October 2003, Vol 5, No 10, pp 49, 51.

177. Research suggests neurosteroid presence in suicide. October 2003, Vol 5, No 10, pp 58, 59.

178. GABA blocker shown to treat anxiety. October 2003, Vol 5, No 10, pp 36, 38.

179. Topiramate prevents headache of pseudotumor cerebri. September 2003, Vol 5, No 9, p24.

180. New rating scale assesses psychogenic movement disorders. August 2003, Vol 5, No 8, pp 16-17.

181. Hypothermia fails to improve outcome in severe head trauma. July 2003, Vol 5, No 7, pp 1-55.

182. Cognitive function decline rates vary according to dementia type. July 2003, Vol 5, No 7, pp 1-25.

183. African-Americans experience more severe MS. July 2003, Vol 5, No 7, p 43.

184. Disability in Multiple Sclerosis: Are abnormal eye movements a predictor? July 2003, Vol 5, No 7, p 43.

185. Effect of topiramate on blood sugar independent of weight loss. July 2003, Vol 5, No 7, p 37.

186. Fourth time’s a charm for topiramate in painful diabetic neuropathy. July 2003, Vol 5, No 7, p 36.

187. Treatment resistant schizophrenia may respond to drug switch. July 2003, Vol 5, No 7, p 33.

188. New test rapidly screens for HIV-related dementia. July 2003, Vol 5, No 7, p 26.

189. Botulinum toxin types A and B effective for certain types of headache. July 2003, Vol 5, No 7, p 16.

190. Trials, postmarketing data support safety of MS drug in pregnancy. July 2003, Vol 5, No 7, pp 44-45.

191. Complementary and alternative medicine hold appeal. June 2003, Vol 5, No 6, pp 1-24.

192. Migraine patients often switch triptans in search of pain relief. June 2003, Vol 5, No 6, pp 5-6.

193. Sumatriptan treats nitroglycerin-induced migraine symptoms. June 2003, Vol 5, No 6, p 4.

194. EEG supports seizure diagnosis in Alzheimer’s. May 2003, Vol 5, No 5, p 64.

195. Antiepileptic drugs alleviate seizures but may not significantly affect epileptogenesis. May 2003, Vol 5, No 5, p 60.

196. Absence of EEG spikes suggests less severe epilepsy. May 2003, Vol 5, No 5, p 60.

197. Image morphing may show key hippocampal changes in epilepsy. April 2003, Vol 5, No 4, p 27, 55.

198. Clinical Advances in the treatment of epilepsy. Special Report, CME program. April 2003.

199. Topiramate may reduce incidence of sleep apnea in epilepsy. April 2003, Vol 5, No 4, p 30.

200. Predictive value of postoperative EEGs in epilepsy varies. April 2003, Vol 5, No 4, p 28.

201. Nonmedical therapies alleviate chronic migraine pain. April 2003, Vol 5, No 4, p 14.

202. Age matters in post-status epilepticus functional outcome. March 2003, Vol 5, No 3, p 42,64.

203. New test effectively spots mild cognitive impairment. March 2003, Vol 5, No 3, p 18.

204. ‘Last resort’ mentality for epilepsy surgery may be outdated. March 2003, Vol 5, No 3, p 1, 45,46.

205. How many stroke patients benefit from rt-PA? February 2003, Vol 5, No 2, p 24.

206. Mannitol for acute stroke: Tonic or toxin? February 2003, Vol 5, No 2, p 23.

207. Is weight loss with zonisamide gender-specific? February 2003, Vol 5, No 2, pp 11-12.

208. Cannabis helps patients ‘feel better’ but fails to relieve MS tremor. January 2003, Vol 5, No 1, p 21-22.

209. Data building on use of newer antiepileptics for pain. January 2003, Vol 5, No 1, p 55.

210. Study questions neurologist role in chronic back pain. November 2002, Vol 4, No 11, p 9-10.

211. Levetiracetam effective in refractory pediatric epilepsy patients. October 2002, Vol 4, No 10, p 11-12.

212. “Love” stories. September 2002, Vol 4, No 9, p 24-25.

213. Statin use linked to reduced Alzheimer’s risk. September 2002, Vol 4, No 9, p 28.

214. Age a major factor in prognosis of malignant astrocytoma patients. August 2002, Vol 4, No 8, p 22-23.

215. Jury out on perioperative prophylaxis of deep vein thrombosis. August 2002, Vol 4, No 8, p 21.

216. AAN honors The West Wing for MS Portrayal. August 2002, Vol 4, No 8, p 27.

217. Vagal nerve stimulation can reduce polytherapy. August 2002, Vol 4, No 8, p 51.

218. Cholinesterase inhibitors improve function. August 2002, Vol 4, No 8, p 59.

219. Oxcarbazepine shown safe in elderly patients. August 2002, Vol 4, No 8, p 78-79.

220. Headache preventives have varying effects on weight. August 2002, Vol 4, No 8, p 6.

221. Formulary, insurance barriers hinder epilepsy care. May 2002, Vol 4, No 5, p 26.

222. MEG improves noninvasive detection of structural brain lesions. April 2002, Vol 4, No 4, p 8.

223. Slow introduction of second agent urged with AED combination. April 2002, Vol 4, No 4, p 8.

224. Risk of injury should be identified case by case. April 2002, Vol 4, No 4, p 7.

225. Jury out on caffeine effects on seizure frequency. April 2002, Vol 4, No 4, p 6.

226. Many eclamptic seizures occur postpartum. March 2002, Vol 4, No 3, p 1.

227. Antiepileptic reduces seizures in children and adults. March 2002, Vol 4, No 3, p 15.

228. Pregnancy registries look to gauge effects of newer antiepileptics. March 2002, Vol 4, No 3, p 14.

229. Medical disorders delay recognition of seizures in elderly. March 2002, Vol 4, No 3, p. 18.

230. Hyponatremia can be managed during switch to AEDs. March 2002, Vol 4, No 3, p 36.

231. Stroke patients at higher risk of death from pneumonia. March 2002, Vol 4, No 3, p 34.

232. Alzheimer’s drug may benefit autism patients. February 2002, Vol 4, No 2, p 45.

233. Decline in functioning predicts nursing home admission in stroke patients. February 2002, Vol 4, No 2, p 22.

234. Galantamine postpones full-time care for Alzheimer’s patients. February 2002, Vol 4, No 2, p 6.

235. Gene map holds great promise for epilepsy research. January 2002, Vol 4, No 1, p 42.

236. Low aspirin doses preferred for vascular disease prevention. January 2002, Vol 4, No 1, p 37.

237. Alzheimer’s-related delusions may be predictable. January 2002, Vol 4, No 1, p 31.

238. Alzheimer’s severity dictates behavior patterns. January 2002, Vol 4, No 1, p 27.

239. Study links migraine to Tourette’s. January 2002, Vol 4, No1, p 1.

240. Lamotrigine for painful polyneuropathy: A new treatment option? Special Report based on a poster presented at the 126^th Annual Meeting of the American Neurological Association, September 30^th-October 3^rd, 2001, Chicago, Illinois.

241. Study shows weight gain, androgen levels in women vary with antiepileptic, November 2001, Vol 3, No 11, p 11.

242. Cause of sudden epilepsy death may be cardiovascular, November 2001, Vol 3, No 11, p. 10.

243. New study compares three antiepileptics in new-onset patients, October 2001, p. 5.

244. Clinicians should be aware of bone disease risk, October 2001, p. 7.

245. Cortical gray matter reductions predict cognitive decline, September 2001, Vol. 3, No. 9.

246. Decreasing VNS pulse width alleviates pain, September 2001, Vol. 3, No. 9, p. 10.

247. New scale measures restless legs syndrome severity, September 2001, Vol. 3, No. 9, p. 15.

248. Oxcarbazepine may benefit trigeminal neuralgia patients, August 2001, Vol. 3, No. 8, p. 57, 59.

249. Pergolide may relieve symptoms of restless legs syndrome, August 2001, Vol. 3, No. 8, p. 1.

250. Chilled MS patients experience less fatigue, August 2001, Vol. 3, No. 8, p. 23.

251. Study finds IV valproate beneficial in episodic headache, August 2001, Vol. 3, No. 8, p. 11.

252. Motor dysfunction may cause abnormal laughter, July 2001, Vol. 3, No. 7, p. 1.

253. Drug registry looks to establish safe practices, May 2001, Vol. 3, No. 5, p. 22.

254. Seizures may have link to menopause, May 2001, Vol. 3, No. 5, p. 22.

255. Repeated seizures may increase myocardial injury risk, May 2001, Vol. 3, No. 5, p. 1,16.

256. Special Report: Carbamazepine extended-release epilepsy therapy, April 2001.

257. Seizure control is linked to increased risk of suicide, April 2001, p. 32.

258. Mixed results seen with classic ketogenic diet in epileptic adults, April 2001, p. 10.

259. Epilepsy linked to leutinizing hormone pulsatility in women, April 2001, p. 10.

260. Risk of brain injury resulting from epileptic seizures higher in men, April 2001, p.33-34.

261. Seizure threat after acute stroke may necessitate drug therapy, April 2001, p. 35

262. More costly invasive stroke test more effective in some patients, March 2001, Vol 3., No. 3, p. 15.

263. Stroke a possible sign of Fabry’s disease, March 2001, Vol. 3, No. 3, p. 15.

264. Pediatric lead exposure may have pronounced effects on brain development, March 2001, Vol. 3, No. 3, p. 1, 13.

265. “I wanted to know what life was”, March 2001, Vol. 3, No. 3, p. 29.

266. Physicians must be aware of potential legal issues, November 2000, Vol. 2, No. 11, p. 1.

267. Investigators discover new neurogenetic disease, November 2000, Vol. 2. No. 11, p. 1.

268. Zonisamide proven effective against new epilepsy cases in Asian study, October 2000, p.21.

269. Lamotrigine benefits refractory epilepsy patients with mental retardation, October 2000, p.11.

270. Modafinil shows long-term narcolepsy benefits, September 2000.

271. Iron deficiency may cause restless leg syndrome, September 2000, p. 17.

272. Women with premenstrual dysphoric disorder may benefit from fluoxetine, July 2000, Vol. 2, No. 7, p.16.

273. Depressed patients may benefit from vagus nerve stimulation. June 2000, Vol. 2, No. 6, p. 1,16.

274. Generalized Convulsive Status Epilepticus. April 2000, Vol. 2, No. 4, p. 14.

275. Oxcarbazepine approved for epilepsy. February 2000, p. 26.

CNS/LTC News

1. Alzheimer’s severity dictates patterns of disruptive behavior. May 2002, Vol 1, No. 2, p. 40-41.

2. Stroke patients at higher risk of death from pneumonia. February 2002, Vol. 1. No. 1, p. 1, 38.

3. Seizures, antiepileptic drug efficacy evaluated in elderly. February 2002, Vol. 1, No. 1, p. 6,7.

4. Epilepsy, AED use prevalent among nursing home residents. February 2002, Vol. 1. No.1. p. 5.

5. Improved epilepsy care requires more paperwork. February 2002, Vol. 1. No. 1. p. 1, 9, 11.

6. Galantamine may reduce costs for Alzheimer’s patient care. February 2002, Vol. 1. No. 1. p. 28, 29.

7. Decline in ADLs predicts nursing home admission in stroke. February 2002, Vol. 1. No. 1. p. 32.

CNS/SeniorCare

1. Behavioral, cognitive effects of levetiracetam mild in healthy elderly volunteers. Winter 2008, Vol 7, No 1, p 6.

2. Older antiepileptic medications predominate in geriatric care. Winter 2007, Vol 6, No 1, p 1, 11.

3. Epilepsy comes with multiple comorbidities in elderly patients. Winter 2007, Vol 6, No 1, p 14.

4. Carotid stenosis more likely in diabetic African-Americans with heart disease. Winter 2007, Vol 6, No 1, p 14.

5. Despite risks, elderly patients benefit from epilepsy surgery. Winter 2007, Vol 6, No 1, p 15.

6. The SPARCL trial: Atorvastatin reduces stroke severity. Winter 2007, Vol 6, No 1, p 17.

DoctorsGuide.com

1. Surgery provides better quality of life than medical therapy for advanced Parkinson’s disease: American Neurological Association 2008, 9/25/08.

2. Glatiramer acetate reduces relapses with lower cost in patients with multiple sclerosis: American Neurological Association 2008, 9/25/08.

3. Rasagiline slows functional decline in patients with Parkinson’s. American Neurological Association 2008, 9/25/08.

4. Oxygen therapy provides benefits for treatment of cluster headache: American Neurological Association 2008, 9/25/08.

5. Lacosamide controls partial-onset epileptic seizures: American Neurological Association 2008, 9/24/08.

6. Extraventricular drain may not improve outcomes in patients with intracranial hemorrhage. American Neurological Association 2008, 9/24/08.

7. Lacosamide decreases peripheral neuropathic pain in diabetics. American Neurological Association 2008, 9/24/08.

8. Tezampanel helps relieve migraine pain. American Neurological Association 2008, 9/24/08.

9. Limited data found to support clobazam as epilepsy treatment. American Neurological Association 2008, 9/24/08.

10. Intravenous immune globulin improves quality of life in patients with chronic inflammatory demyelinating polyneuropathy. American Neurological Association 2008, 9/24/08.

11. Rotigotine safe for advanced Parkinson’s disease. American Neurological Association 2008, 9/24/08.

12. Acute multiple sclerosis relapses rarely result in permanent disability. American Neurological Association 2008, 9/24/08.

13. Disease modifying drugs tie for efficacy in multiple sclerosis. American Neurological Association 2008, 9/24/08.

14. Montreal cognitive assessment more sensitive to cognitive deficits than mini-mental status examination for Parkinson’s disease. American Neurological Association 2008, 9/24/08.

15. Immediate switch from donepezil tablets to rivastigmine patch well tolerated. American Neurological Association 2008, 9/24/08.

16. Extended-release memantine safe and effective for moderate to severe Alzheimer’s disease. American Neurological Association 2008, 9/24/08.

17. Adverse events from lacosamide are dose-related. American Neurological Association 2008, 9/24/08.

18. Lacosamide safe in combination with other antiepileptic drugs. American Neurological Association 2008, 9/24/08.

19. Once daily armodafinil sustains wakefulness throughout the day in patients with narcolepsy. American Neurological Association 2008, 9/24/08.

EpilepsyAdvocate

1. Epilepsy and Aging. 2008 Vol 7, pp 7-9.

EpilepsyUSA

1. Sudden unexpected death in epilepsy (SUDEP)-rare but deadly. 2008, issue 2, p 17,18.

2. Epilepsy and ADHD. 2008, issue 4, p 12, 13.

Epilepsy.com

1. Challenging Cases: If at first you don’t succeed… http://professionals.epilepsy.com/page/case_3.html, 4/26/07.

2. Study confirms link between seizures and menstruation in some women. http://www.epilepsy.com/articles/ar_1147959540.html, 5/18/06.

3. Young children fail to gain weight on valproate. http://www.epilepsy.com/articles/ar_1147954409.html, 5/18/06.

4. Job experience important before epilepsy surgery. http://www.epilepsy.com/articles/ar_1147952469.html, 5/18/06.

5. Ketogenic diet as long term treatment satisfies parents. http://www.epilepsy.com/articles/ar_1146742473.html, 5/4/06.

6. Professionals in Epilepsy Care Symposium: Controversies and challenges of EEG monitoring, 2/06/06,

http://www.epilepsy.com/articles/ar_1139251543.html.

7. Translating research into cures, 2/06/06. http://www.epilepsy.com/articles/ar_1139251313.html.

8. Researchers discuss use of botanicals as treatment for epilepsy, 2/06/06. http://www.epilepsy.com/articles/ar_1139251167.html.

Medscape Neurology and Neurosurgery

1. Vigabatrin (Sabril): A new epilepsy drug-with strings attached. http://www.medscape.com/viewarticle/714332

2. Seizure calendars for the 21^st century. December, 2009, http://www.medscape.com/viewarticle/714318

3. AAN 2009:Practice parameter updates on women with epilepsy, electroencephalographic monitoring (video with Dr. Selim Benbadis), American Academy of Neurology 61^st Annual Meeting, April 25-May 2, 2009, http://www.medscape.com/viewarticle/703042

4. Current and emerging adjunctive epilepsy therapies, American Epilepsy Society, Seattle, Washington, 2008, http://www.medscape.com/viewarticle/586180.

5. Monotherapy in Select Epilepsy Populations, American Epilepsy Society, Seattle, Washington, 2008, http://www.medscape.com/viewarticle/586183.

6. Highlights from the World Stroke Conference 2008, http://cme.medscape.com/viewprogram/18729.

7. Update on Chronic Pain Treatments from the American Academy of Pain Management, Nashville, TN, 2008, http://cme.medscape.com/viewarticle/581929.

8. Key Findings in Multiple Sclerosis Presented at the 60^th Annual Meeting of the American Academy of Neurology: May 30^th, 2008. http://www.medscape.com/viewprogram/14659 (CME).

9. Medscape Special Session Coverage on the 2008 American Psychiatric Association Annual meeting: May 5, 2008. http://www.medscape.com/viewarticle/574067.

10. Repercussions of Abuse, Neglect, and Trauma on the Neurobiology of the Brain and Their Implications for Prevention, Diagnosis and Treatment. American Psychiatric Association, May 6, 2008. http://www.medscape.com/viewarticle/574158.

11. Patients’ Cultural and Spiritual Beliefs Influence Their Diagnosis, Treatment, and Management. American Psychiatric Association, May 7, 2008. http://www.medscape.com/viewarticle/574203.

12. Excessive Sleepiness: Winter 2007-2008. CME, March, 2008. http://www.medscape.com/viewprogram/8811

13. Recognizing and Treating Excessive Sleepiness in Primary Care: Characteristics and Consequences, august 30, 2007. http://www.medscape.com/viewprogram/7709. CME.

14. American Academy of Neurology 59^th Annual Meeting, 2007, Boston, MA, Epilepsy Diagnosis and Management. http://www.medscape.com/viewprogram/7567_pnt.

15. American Academy of Neurology 59^th Annual meeting, 2007, Boston, MA, Sleep and Sleep Disorders. http://www.medscape.com/viewprogram/7567_pnt.

16. 1^st North American Regional Epilepsy Congress, 2006, San Diego, CA. Women and epilepsy. http://www.medscape.com/viewarticle/551420.

17. 1^st North American Regional Epilepsy Congress, 2006, San Diego, CA. Meeting Highlights. http://www.medscape.com/viewarticle/551419.

18. 1^st North American Regional Epilepsy Congress, 2006, San Diego, CA. New findings from the 60^th Annual Meeting of the American Epilepsy Society: An interview with Robert Gross, MD, PhD. http://www.medscape.com/viewarticle/549148.

19. American Neurological Association, 2006, Chicago, Il. Highlights of the 131^st Annual meeting of the American Neurological Association. http://www.medscape.com/viewarticle/548560.

20. American Academy of Neurology 2006, San Diego, CA. Epilepsy diagnosis and management. CME Conference report. http://www.medscape.com/viewarticle/536363.

21. Joint meeting of the American Epilepsy Society and the American Clinical Neurophysiology Society, 2005. Conference report. http://www.medscape.com/viewarticle/522349?src=search.

22. Journal Scan-Sleep medicine. December 2005/January 2006. http://www.medscape.com/viewprogram/5181?src=hp26.cme.

23. Journal Scan-Sleep medicine. CME program. http://www.medscape.com/viewarticle/512695.

24. American Academy of Neurology 57^th Annual meeting. Conference report. Current Perspectives in Insomnia. Volume 5. CME program. http://www.medscape.com/viewprogram/4148_pnt.

25. American Epilepsy Society 58^th Annual meeting. Selected posters and abstracts: Use of antiepileptic drugs in women of childbearing age. http://www.medscape.com/viewprogram/3730_pnt.

26. Antiepileptic drugs and pregnancy registry data: An expert interview with Martha Morrell, MD. Video interview at the American Epilepsy Society, New Orleans, December 5, 2004. http://www.medscape.com/viewarticle/495760?src=search.

27. Conference Report-Highlights of the American Psychiatric Association 56^th Institute on Psychiatric Services (CME). http://www.medscape.com/viewarticle/495341?src=sr.

28. The epilepsy continuum: From age to age. CME program. http://www.medscape.com/viewprogram/3454?src=search

29. Conference report-Highlights of insomnia and sleep disorder research from the 56^th annual meeting of the American Academy of Neurology at http://www.medscape.com/viewarticle/478839?src=sr.

30. American Epilepsy Society conference coverage, Philadelphia, PA, 2001. Neuropharmacology of antiepileptic drugs at http://www.medscape.com/viewarticle/423305.

31. World Congress of Neurology conference coverage, London, England, June 17, 2001 at http://www.medscape.com/Medscape/CNO/2001/WCN/public/Conference.cfm?conference_id=121.

32. Highlights from epilepsy presentations at the 53^rd Annual Meeting of the American Academy of Neurology, May 5-11, 2001 at http://www.medscape.com/Medscape/CNO/2001/AAN/AAN-08.html.

33. Highlights from a workshop on antiepileptic drug (AED) monotherapy indications, March 8, 9, 2001, NIH/NINDS Neuroscience Center, Rockville, MD, at:http://www.medscape.com/Medscape/Neurology/journal/2001/v03.n02/…/pnt-mn0416.wiln.htm.

34. Key Reports from the 68^th Annual Meeting of the Association of Neurological Surgeons, April 8-13,

2000, San Francisco, CA; http://www.medscape.com/medscape/Neurology/journal/2000/v02.n03/mn…/mn0524.wiln.htm.

35. Conference summaries from the 125^th Annual Meeting of the American Neurological Association, October 15-18, 2000, Boston, MA; http://www.medscape.com/conferences/ANA2000.

Medscape Blog

Neuro Notes

February 6, 2010 Practice Parameter Supports Botulinum Toxin A for Spasticity http://boards.medscape.com/forums?128@1019.PzQwaqS9mfa@.29fa164b!comment=1&cat=All

February 1, 2010 Film Contest Debuts at American Academy of Neurology

http://boards.medscape.com/forums?128@@.29f9eecf!comment=1

January 22, 2010 Mild Traumatic Brain Injury/Concussions-New Department of Defense Guidelines

http://boards.medscape.com/forums?128@@.29f95ecb!comment=1

January 7, 2010 Amyotrophic Lateral Sclerosis AAN Practice Parameter Update

http://boards.medscape.com/forums?128@689.LszoaIuamR6@.29f8d4f7!comment=1

December 21, 2009 American Epilepsy Society Meeting 2009-Wrap Up http://boards.medscape.com/forums?128@796.xOh3aNCkjaN@.29f874a3!comment=1&cat=All

December 9, 2009 American Epilepsy Society 2009 Day #5: Consensus Definition of Drug Resistant Epilepsy http://boards.medscape.com/forums?128@796.xOh3aNCkjaN@.29f83d5d!comment=1

December 8, 2009 American Epilepsy Society 2009 Day #4-Story Landis and the Presidential Symposium http://boards.medscape.com/forums?128@796.xOh3aNCkjaN@.29f8314f!comment=1

December 7, 2009 American Epilepsy Society-Day #3 Exhibit Hall Opens and the Temporal Lobe Club

http://boards.medscape.com/forums?128@796.xOh3aNCkjaN@.29f82dcc!comment=1&cat=All

December 1, 2009 American Epilepsy Society 2009: A Survival Guide http://boards.medscape.com/forums?128@796.xOh3aNCkjaN@.29f8136f!comment=1&cat=All

November 16, 2009 Generic Drugs: Upcoming Meeting and a Call for Papers

http://boards.medscape.com/forums?128@796.xOh3aNCkjaN@.29f7b9f3!comment=1

November 2, 2009 Neuroenhancement-Pathway to a Better Brain? http://boards.medscape.com/forums?128@1019.jYbga8lyflc@.29f765ba!comment=1

October 18, 2009 Microcephaly Practice Parameter: Investigative Approach and Recommendations, http://boards.medscape.com/forums?128@1019.jYbga8lyflc@.29f7068f!comment=1

October 5, 2009 Bariatric Neurology: The Next Subspeciality? http://boards.medscape.com/forums?128@1019.OROvaAJfebX@.29f6aa18!comment=1&cat=All

September 23, 2009 Boxing: Round Two, http://boards.medscape.com/forums?128@1019.OROvaAJfebX@.29f64b14!comment=1&cat=All

September 1, 2009 Memories To Keep and Those To Forget, http://boards.medscape.com/forums?128@1019.OROvaAJfebX@.29f5df57!comment=1

August 16, 2009 The Doctor (Or Whoever) Will See You Now... http://boards.medscape.com/forums?128@1019.OROvaAJfebX@.29f58ed4!comment=1

July 31, 2009 PFO-Pathological or a Normal Variant? http://boards.medscape.com/forums?128@1019.OROvaAJfebX@.29f538e7!comment=1

July 16, 2009 Nanotechnology-When Good Things Come in Small Packages, http://boards.medscape.com/forums?128@1019.OROvaAJfebX@.29f4d964!comment=1

June 22, 2009 EEG: A test for diagnosis or misdiagnosis? http://boards.medscape.com/forums?128@1019.OROvaAJfebX@.29f44c72!comment=1

May 29, 2009 Is There a Doctor on Board? http://boards.medscape.com/forums?128@1019.OROvaAJfebX@.29f3bb78!comment=1

May 2, 2009 Bullets, Bombs, and Fists, http://boards.medscape.com/forums?128@1019.OROvaAJfebX@.29f2e100!comment=1

May 1, 2009 Coffee and Chocolate-Still Legal in Seattle , http://boards.medscape.com/forums?128@1019.OROvaAJfebX@.29f2de1f!comment=1&cat=All

April 30, 2009 "All About Multiple Sclerosis, All the Time," http://boards.medscape.com/forums?128@1019.OROvaAJfebX@.29f2ce91!comment=1

April 29, 2009 Just Because You Know It's True Doesn't Make It So, http://boards.medscape.com/forums?128@1019.OROvaAJfebX@.29f2a1c4!comment=1

April 28, 2009 Women With Epilepsy Practice Parameters-THE LAUNCH! http://boards.medscape.com/forums?128@1019.OROvaAJfebX@.29f28cf0!comment=1

April 13, 2009 Excitement and Trepidation in Anticipation of the 61st Annual American Academy of Neurology Meeting , http://boards.medscape.com/forums?128@1019.OROvaAJfebX@.29f1fe42!comment=1

Neurology Now

1. Vagus Nerve Stimulation, Epilepsy, and Depression, July/August, 2009

2. Eating well for epilepsy. January/February 2009;17,18,19,23.

3. Proceed with caution. Driving advice for people with epilepsy, Parkinson’s, and Alzheimer’s, and their families. July/August 2008;4(4):17,18,23.

Neurology Today

1. International effort to improve diagnosis of HIV-related dementia in developing countries. November 2004, Vol 4, Number 11, pages 66, 67. 68, 69, 70.

2. Survey: Increasingly, noncompliance with AED regimens leads to more seizures. November 2003, Volume 3, Number 11, page 23.

3. Early surgery recommended for children with focal cortical dysplasia and epilepsy. May 2003, Volume 3, Number 5, pages 32, 33.

4. Survey suggests oral contraceptives may be a risk for seizures. April 2003, Volume 3, Number 4, page 10.

5. Neurologists and others need to bone up on women’s health issues in epilepsy. April 2003, Volume 3, Number 4, pages 10-11.

6. Is sleep deprivation for pediatric EEGs an unnecessary burden? February 2002, Volume 3, Number 2, page 32.

7. New study finds long-term cognitive decline is infrequent with CABG patients. September 2002, Volume 2, Number 9, page 1.

8. What neurologists can do to improve end-of-life care. July 2002, Volume 2, Number 7, page 14.

9. Twenty percent of Netherlands ALS patients choose death-why? July 2002, Volume 2, Number 7, page 1.

10. Is there a doctor on the plane? Report documents neurological events in flight. June 2002 supplement, special edition, page 1.

11. Report recommends systematic screening of side effects of epilepsy drugs. June 2002 supplement, special edition.

Neurology Reviews

1. Diagnostic evaluations for Alzheimer’s disease and MCI. Volume 16, No 8, p 28, August 2008.

2. Health diet, exercise, and socialization may protect against dementia. Volume 16, No 8, p 37, August 2008.

3. Lessons from the epilepsy lab: Can better surgical treatments be developed? Volume 16, No 3, p 36, March 2008.

4. FDA warns of suicide risk with antiepileptic drugs. Volume 16, No 3, p 1, 39, March 2008.

5. Environmental factors influence incidence of status epilepticus. Volume 16, No 2, p 12, February 2008.

6. Pseudopharmacoresistance: is inadequate dosing to blame? Volume 16, No 2, p 21, February 2008.

7. New antiepileptic drugs in development. Volume 16, No 1, p 8, 9, January 2008.

8. Craniectomy improves survival after massive stroke. Volume 15, Number 12, p 9, December 2007.

9. CT scans may aid patients with first seizures in the emergency department. Volume 15, Number 12, p 31, December 2007.

10. Prior insomnia and family history are risk factors for new-onset insomnia. November 2007

11. A new screening battery identifies safe drivers with Parkinson’s disease. November 2007

12. Natalizumab withdrawal poses risk for new T2 lesions in patients with MS. November 2007

13. Early treatment of TIA and minor stroke reduces risk of recurrent stroke. November 2007

14. Sleep improves relational memory. September 2007;15(9):54.

15. Early treatment of clinically isolated syndrome delays disability progression. July 2007;15(7):55.

16. Drug interactions are likely in epilepsy patients. July 2007;15(7):40.

17. Smoking rates are higher in patients with MS. July 2007;15(7):55.

18. Botanicals might be a source for epilepsy treatment. February 2007;15(2):25.

19. Menstrual cycle length and ovulation rates are linked to seizure frequency. June 2006;14(6):8,9.

20. Epilepsy education has long-term effects. April 2006;14(4):27.

21. High-altitude climbers risk brain damage. March 2006;14(3):30-31.

22. High mortality in persons with epilepsy. January 2006;14(1):10-12.

23. Genetic epilepsy found in Gypsy family. December 2005;13(12):62.

24. Computerized seizure calendar assists patient care. November 2005;13(11):57.

25. Benign imaging abnormalities common in children with headache. August 2005;13(8):3,5,6.

26. Diabetes not the only etiology for neuropathy. July 2005;13(7):23.

27. Daily seizure diaries more accurate than self-reporting. March 2005;13(3):11,14.

28. Disturbed sleep more common in patients with epilepsy. March 2005;13(3):49.

29. Syncope may be psychogenic. March 2005;13(3):65.

30. Depression after CABG predicts return of angina. January 2005;13(1):27.

31. Ischemic stroke patients at high risk for MI. January 2005;13(1):32.

32. D-Dimer levels correlate with stroke severity. January 2005;13(1):64, 65.

33. Refractory epilepsy can be identified early. January 2005;13(1):1, 66, 67.

34. Restless legs syndrome may worsen with treatment. October 2004;12(10):16.

35. Intravenous iron calms restless legs. October 2004;12(10):16.

36. Modafinil alleviates nighttime sleepiness in shift workers. September 2004;12(9):31.

37. Researchers narrow search for restless legs syndrome gene. August 2004;12(8):20.

38. Guidelines clarify role of new antiepileptic drugs. July 2004;12(7):54-55.

39. Protecting against stroke after TIA. January 2004;12(1):49.

40. MS therapy-narrowing the gap between short-term answers and long-term questions. January 2004;12(1):40.

41. Assessing the impact of stroke progression. January 2004;12(1):15.

42. Beyond the three-hour window-more patients could benefit from t-PA. January 2004;12(1):55-58.

43. Will new criteria for certifying stroke centers improve care? January 2004;12(1):54-55.

44. New AEDs offer improved seizure control and tolerability in elderly with new-onset seizures. October 2003;11(10):47,50.

45. National conference addresses the problems faced by people with epilepsy. September 2003;11(9):40.

46. Vascular dementia versus Alzheimer’s disease-clinical differences. February 2003;11 (2):11.

47. Who is at risk for post-stroke dementia? February 2003;11 (2):10, 11.

48. How disabling is restless legs syndrome? February 2003;11 (2):20, 21,22.

49. Functional imaging provides insight into the neural substrate of anosognosia. January 2003;11(1):8-10.

50. Research awakens cause of narcolepsy. August 2002;10 (8):16, 17.

51. Unraveling the mystery of the MS lesion. August 2002;10 (8):1,12,13.

52. Rare metabolic disease can now be detected with selective ion monitoring. June 2002.

53. Neural cell transplants may hold promise for Huntington’s Disease. January 2002, Volume 10, Number 1, p. 45.

54. Assessing migraine pain-is the current4-point scale inadequate? January 2002, Volume 10, Number 1, p. 24.

55. Pharmacogenomics-The New Challenge in Drug Development. December 2001, Volume 9, Number 12, p. 1.

56. Where does neurostimulation fit in epilepsy management? February 2001, pp. 23-26.

57. Uncovering clues to the neurobiologic basis of emotion and consciousness. January 2001, Volume 9, Number 1, page 1.

58. Seizures force patients to speak in another tongue. May 2000, p.36

59. Tricyclic antidepressants-A risk factor for epilepsy? April 2000, Volume 8, Number 4, pp. 1, 28.

60. More seizures, less anxiety? April 2000, Volume 8, Number 4, pp. 34-36.

61. Epilepsy and pregnancy. March 2000, Volume 8, Number 3, pp. 39-44.

62. Some MS patients have “dramatic” responses to plasma exchange. March 2000, p. 1.

63. Nonepileptic seizures may be underappreciated in men. February 2000, Volume 8, Number 2, p. 31.

64. Could alcohol and caffeine put a brake on stroke? January 2000, Volume 8, Number 1, p. 22.

65. A “spectrum of somnolence” reported in patients taking dopamine agonists. November 1999, p. 29.

66. Pregnancy, folic acid, and epilepsy. October 1999, p. 11.

Neuropsychiatry Reviews

1. Deep brain stimulation triggers enhanced memory in obese patient. Volume 9, No 4, p 10, April 2008.

2. FDA warns of suicide risk with antiepileptic drugs. Volume 9, No 3, p 11, March 2008.

3. PTSD risk tripled in deployed soldiers with combat exposure. Volume 9, No 3, p 1, 39, March 2008.

4. Light therapy benefits women with bipolar disorder. February 2008, Vol 9, No 2, p 12.

5. Patients with schizophrenia have higher mortality rate. November 2007.

6. Prior insomnia and family history are risk factors for new onset insomnia. September 2007, Vol 8, No 9, p 26.

7. Insomnia in college students is associated with poor mental health. August 2007, Vol 8, No 8, p 19.

8. Depression after CABG predicts return of angina. December 2004, Vol. 5, No. 9, p. 14.

9. A Diagnostic test for ADHD? June 2000, Vol. 1, No. 3, p. 32.

Pain Medicine News

1. Migraine with aura increases risk for cerebellar stroke in women. September 2009, Vol 7, No 9, p 9.

2. PFO closure alleviates migraine in selected patients. September 2009, Vol 7, No 9, p 10.

3. Methadone use may cause sudden death. April/May 2008, Vol 6, No 4, p 6.

4. Antiepileptic drugs increase suicide risk. March 2008, Vol 6, No 3, p 1, 11.

5. Rapid relief of migraine and allodynia with occipital nerve block. September/October 2006, Vol 4, No 5, p 31.

6. Early treatment with spinal cord stimulation likely to succeed. September/October 2006, Vol 4, No 5, p 40.

7. Controversies in pain: Can PFO closure treat migraine? September/October 2006, Vol 4, No 5, p 1, 30.

8. Study shows symptoms, treatment outcomes of IIH in children. July/August, 2006, Vol 4, No 4, p 13, 31.

9. Migraine onset early in life linked to familial migraine. November/December, 2005, Vol 3, No 6, p 15.

10. Gastrokinetic agent plus triptan speeds migraine relief. November/December, 2005, Vol 3, No 6, p 16.

11. Synthetic hormone treats refractory low pressure headaches. November/December, 2005, Vol 3, No 6, p 16.

12. Noncompliance, medication overuse linked to transformed migraine. September/October, 2005, Vol 3, No 5, p 9.

13. Episodic tension-type headache found more common in those over 70. September/October, 2005, Vol 3, No 5, p 9.

14. Cannabis-based medicine improves sleep in patients with MS, pain. September/October, 2005, Vol 3, No 5, p 18.

15. Headache distribution is different in adolescents versus adults. March/April, 2005, Vol 3, No 2, p 7, 20.

16. Patients with transformed migraine have lower pain tolerance. March/April, 2005, Vol 3, No 2, p 7.

17. Withdrawal from analgesic overuse makes brain hypometabolic. January/February, 2005, Vol 3, No 1, p 21.

18. Infertile women significantly more likely to have migraines. January/February, 2005, Vol 3, No 1, p 22, 23.

19. Opioid program can be used to manage intractable headache. November/December, 2004, Vol 2, No 6, p 19, 20, 21.

20. Migraine with aura increases risk of stroke in female patients. September/October 2004, Vol 2, No 5, p 7.

21. Migraine patients’ high homocysteine linked with abnormal MRI. September/October 2004, Vol 2, No 5, p 7, 8.

22. Harkoseride cuts diabetic neuropathy-related pain, improves sleep. September/October 2004, Vol 2, No 5, p 16.

23. Rapid-release sumatriptan may shorten time to migraine relief. September/October 2004, Vol 2, No 5, p 21.

24. Zolmitriptan nasal spray offers rapid migraine relief. September/October 2004, Vol 2, No 5, p 1, 21,

25. Coenzyme Q10 reduces migraine frequency and associated nausea. July/August 2004, Vol 2, No 4, p 1, 23.

26. C-Reactive protein found to be elevated in migraine patients. July/August 2004, Vol 2, No 4, p 20, 21.

27. Topiramate reduces pain scores in patients with diabetic neuropathy. November/December 2003, Vol 1, No 6, p 21.

28. Botulinum toxin treats headaches with mixed efficacy. September/October 2003, Vol 1, No 5, pp 1, 5.

29. Presence of cutaneous allodynia inhibits triptan response. July/August 2003, Vol 1, No 4, pp 1, 5.

30. OTC analgesic combo beats sumatriptan for early migraine TX. May/June 2003, Vol 1, No 3, pp 5-6.

31. Patients switch triptans due to incomplete or no pain relief. May/June 2003, Vol 1, No 3, p 5.

PlanetRx.com Epilepsy Column

1. Driving and epilepsy. 5/11/00

2. Is pregnancy safe for women with epilepsy? 6/22/00

3. How common are seizures in older people? 8/11/00

4. Flashing lights and seizures. 9/21/00